METABOLISM OF YM155 MONOBROMIDE, A NOVEL SURVIVIN SUPPRESSANT: IN VITRO SPECIES COMPARISON AND IDENTIFICATION OF METABOLITES IN RATS

被引：0
|
作者：
Sohda, Kin-ya [1 ]
Suzuki, Katsuhiro [1 ]
Nakamura, Eiji [2 ]
Minematsu, Tsuyoshi [1 ]
Hashimoto, Tadashi [1 ]
Imai, Harumitsu [1 ]
Usui, Takashi [1 ]
Kawamura, Akio [1 ]
Kamimura, Hidetaka [1 ]
机构：
[1] Astellas Pharma Inc, Drug Metab Res Labs, Tokyo, Japan
[2] Astellas Res Serv Co Ltd, Drug Anal & Metab Res Dept, Tokyo, Japan
来源：
DRUG METABOLISM REVIEWS | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
356
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [41] PHASE I STUDY OF YM155, SELECTIVE SURVIVIN SUPPRESSANT PLUS ERLOTINIB IN PATIENTS WITH EGFR-MUTANT ADVANCED NSCLC
    Shimizu, Toshio
    Okamoto, Isamu
    Okamoto, Kunio
    Nishio, Kazuto
    Sakai, Kazuko
    Aida, Hidemi
    Hashii, Chiaki
    Aoyama, Koji
    Morishita, Maiko
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2014, 25
  • [42] Schedule-dependent antitumor activity of YM155, a novel small molecule survivin suppressant, in experimental human hormone refractory prostate carcinoma xenograft
    Nakahara, T
    Takeuchi, M
    Kinoyama, I
    Minematsu, T
    Matsuhisa, A
    Kita, A
    Tominaga, F
    Yamanaka, K
    Sasamata, M
    ANNALS OF ONCOLOGY, 2006, 17 : 38 - 38
  • [43] YM155, a Survivin Suppressant, Induces Cell Death Via Suppression Of c-Myc Expression In Multiple Myeloma Cells
    Ito, Shigeki
    Asahi, Maki
    Sasaki, Ryousei
    Oyake, Tatsuo
    Tamura, Hideto
    Ishida, Yoji
    BLOOD, 2013, 122 (21)
  • [44] Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia
    Chen, Jing
    Pise-Masison, Cynthia A.
    Shih, Joanna H.
    Morris, John C.
    Janik, John E.
    Conlon, Kevin C.
    Keating, Anne
    Waldmann, Thomas A.
    BLOOD, 2013, 121 (11) : 2029 - 2037
  • [45] YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model
    Nakahara, Takahito
    Yamanaka, Kentaro
    Hatakeyama, Shinji
    Kita, Aya
    Takeuchi, Masahiro
    Kinoyama, Isao
    Matsuhisa, Akira
    Nakano, Kenji
    Shishido, Takao
    Koutoku, Hiroshi
    Sasamata, Masao
    ANTI-CANCER DRUGS, 2011, 22 (05) : 454 - 462
  • [46] Formulation Design and Evaluation of Liposomal Sepantronium Bromide (YM155), a Small-Molecule Survivin Suppressant, Based on Pharmacokinetic Modeling and Simulation
    Kohsuke Shakushiro
    Hiroki Kawano
    Mari Nakata
    Aya Kita
    Atsushi Maeda
    Shunsuke Watanabe
    Kazuhiro Sako
    Naoto Oku
    Pharmaceutical Research, 2015, 32 : 238 - 247
  • [47] A phase II, monotherapy study of YM155, a novel survivin suppressant, in previously treated advanced stage non-small cell lung cancer (NSCLC)
    Giaccone, Giuseppe
    Zatloukal, Petr
    Roubec, Jaromir
    Musil, Jaromir
    Kuta, Milan
    van Klaveren, R. J.
    Chaudhary, Subhash
    Gunther, Adrie
    Shamsili, Setareh
    Kazei, Dmitri
    Verbeeck, Frank
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3597S - 3597S
  • [48] A phase II study of YM155, a novel survivin suppressant, administered by 168 hour continuous infusion in patients with unresectable stage III or stage IV melanoma
    Gonzalez, R.
    Lewis, K.
    Samlowski, W.
    Cranmer, L.
    Catlett, J.
    Kirkwood, J.
    Whitman, E.
    Lawson, D.
    Bartels, P.
    Drake, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Liquid chromatography-tandem mass spectrometric assay for the light sensitive survivin suppressant sepantronium bromide (YM155) in mouse plasma
    Dolman, M. Emmy M.
    den Hartog, Ilona J. M.
    Molenaar, Jan J.
    Schellens, Jan H. M.
    Beijnen, Jos H.
    Sparidans, Rolf W.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 92 : 144 - 148
  • [50] Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of YM155, a novel small-molecule survivin suppressant, in dog plasma
    Minematsu, Tsuyoshi
    Felder, Laurie
    Oppeneer, Todd
    Sakazume, Masashi
    Oikawa, Keishi
    Hashimoto, Tadashi
    Usui, Takashi
    Kamimura, Hidetaka
    BIOMEDICAL CHROMATOGRAPHY, 2008, 22 (07) : 763 - 769
12345